Werewolf Therapeutics, Inc. (HOWL)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Werewolf Therapeutics, Inc.’s filings yet. We add companies and filings all the time.
Track HOWL and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | Aug 14, 2026 | $644.25M |
| Vanguard Capital Management | Aug 13, 2026 | $438.47M |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $242.8M |
| GEODE CAPITAL MANAGEMENT, LLC | Aug 12, 2026 | $120.89M |
| BANK OF AMERICA CORP /DE/ | Aug 14, 2026 | $111.83M |
HOWL's filings are public. The insight is one click away.
Scrutar's AI reads every HOWL filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a HOWL filing.
Get an email when HOWL files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.